The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis
Open accessAbstract
Objectives To evaluate the efficacy of goserelin versus a low-dose cyclic oral contraceptive (OC) in improving pelvic pain in women with endometriosis and to compare recurrence of symptoms during follow-up.Design Open-label, randomized trial.Setting University hospital endometriosis center.Patients Fifty-seven women with moderate or severe pelvic pain and laparoscopically diagnosed endometriosis.Interventions Six-month treatment with goserelin depot (n = 29) or a low-dose cyclic OC (n = 28) followed by 6-month follow-up.Main outcome measures Variation in severity of symptoms during treatment and at the end of follow-up as shown by a linear analog scale and a verbal rating scale.Results At 6 months of treatment, a significant reduction in deep dyspareunia was observed in both groups, with goserelin superior to the OC at linear analog scale assessment. Nonmenstrual pain was diminished on both scales without differences between treatments. Women taking the OC experienced a significant reduction in dysmenorrhea. At the end of follow-up, symptoms reappeared without differences in severity between the groups.Conclusions Low-dose cyclic OCs may be a valuable alternative for the treatment of dysmenorrhea and nonmenstrual pain associated with endometriosis. Symptoms recurred in most subjects 6 months after drug withdrawal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on our previous experience, the proportion of endometriosis patients satisfied with OC treatment is $65% (20,57).”
From A stepped-care approach to symptomatic endometriosis management: A participatory research initiative (2018) · cites this paper as [57]
In the citing paper
“The results consistently confirmed that progestins and OCs are effective in relieving pain”
From “Waiting for Godot”: a commonsense approach to the medical treatment of endometriosis (2011) · cites this paper as Vercellini et al., 1993
In the citing paper
“generally well-tolerated”
From “Waiting for Godot”: a commonsense approach to the medical treatment of endometriosis (2011) · cites this paper as Vercellini et al., 1993
In the citing paper
“and not inferior to danazol, GnRH agonists and aromatase inhibitors”
From “Waiting for Godot”: a commonsense approach to the medical treatment of endometriosis (2011) · cites this paper as Vercellini et al., 1993
Citations
Cites
Revised American Fertility Society Classification of Endometriosis: 1985
(1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48430-x · Cited by 1,803
An epidemiologic study of young women with dysmenorrhea
Andersch, B., & Milsom, I. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90433-1 · Cited by 549
Endometriosis: Role of Ovarian Steroids in Initiation, Maintenance, and Suppression
diZerega, G. S., Barber, D. L., & Hodgen, G. D. (1980) · Fertility and Sterility · doi:10.1016/s0015-0282(16)44780-1 · Cited by 290
Dlugi, A. M., Miller, J. D., & Knittle, J. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53755-8 · Cited by 279
Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness
Biberoglu, K. O., & Behrman, S. J. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90478-6 · Cited by 267
Candiani, G. B., Fedele, L., Vercellini, P., Bianchi, S., & Nola, G. D. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)91636-6 · Cited by 134
Self-citationEvers, J. L. H. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59062-1 · Cited by 118
Histologic study of ovarian endometriosis after hormonal therapy
Nisolle-Pochet, M., Casanas-Roux, F., & Donnez, J. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59766-0 · Cited by 111
A comparison of nafarelin acetate and danazol in the treatment of endometriosis
Kennedy, S., Williams, I. A., Brodribb, J., Barlow, D. H., & Shaw, R. W. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53574-2 · Cited by 74
Buserelin versus danazol in the treatment of endometriosis-associated infertility
Fedele, L., Bianchi, S., Arcaini, L., Vercellini, P., & Candiani, G. B. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90739-4 · Cited by 64
Self-citationFedele, L., Arcaini, L., Bianchi, S., Baglioni, A., & Vercellini, P. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1097/00006250-198906000-00019 · Cited by 59
Self-citationRisk Factors for Endometrioid, Mucinous and Serous Benign Ovarian Cysts
PARAZZINI, F., LA VECCHIA, C., FRANCESCHI, S., NEGRI, E., & CECCHETTI, G. (1989) · International Journal of Epidemiology · doi:10.1093/ije/18.1.108 · Cited by 58
Pelvic denervation for chronic pain associated with endometriosis : Fact or fancy?
Vercellini, P., Fedele, L., Bianchi, S., & Candiani, G. B. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90322-i · Cited by 54
Self-citationThe morphologic effect of short-term medical therapy of endometriosis
Brosens, I. A., Verleyen, A., & Cornillie, F. J. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(87)80297-1 · Cited by 52
Endometriosis: treatment with gonadotropin-releasing hormone agonist Buserelin
Franssen, A. M. H. W., Kauer, F. M., Chadha, D. R., Zijlstra, J. A., & Rolland, R. (1989) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60544-7 · Cited by 36
Treatment of Endometriosis with Estrogen-Progestin Combination and Progestogens Alone
Moghissi, K. S. (1988) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-198812000-00008 · Cited by 35
Hormonal Therapy of Endometriosis
Metzger, D. A., & Luciano, A. A. (1989) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(21)00141-8 · Cited by 32
Fraser, H. M., Sandow, J., Cowen, G. M., Lumsden, M. A., Haining, R. E. B., & Smith, S. K. (1990) · Fertility and Sterility · doi:10.1016/s0015-0282(16)53217-8 · Cited by 20
TREATMENT OF ENDOMETRIOSIS: A STUDY OF MEDICAL MANAGEMENT
Noble, A. D., & Letchworth, A. T. (1980) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1980.tb04607.x · Cited by 16
Research works printed but not linked: 1
- Vercellini P, Crosignani PG. Epidemiology of endometriosis. In: Brosens I, Donnez J, editors. Proceedings of the 3rd World Congress on Endometriosis; 1992 June 1–3; Brussels. Casterton Hall: Parthenon Publishing. In press.
Cited by
Sorted by citations
ESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211
Bulun, S. E. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804690 · Cited by 1,772
Clinical Management of Endometriosis
Falcone, T., & Flyckt, R. L. (2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002469 · Cited by 582
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
Diagnosis and management of dysmenorrhoea
Proctor, M. L., & Farquhar, C. M. (2006) · BMJ · doi:10.1136/bmj.332.7550.1134 · Cited by 520
Metadata
- Authors
- Vercellini, P., Trespidi, L., Colombo, A., Vendola, N., Marchini, M., & Crosignani, P. G.
- Affiliations
- University of Milan (IT)
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 1993-07
- Volume
- 60
- Issue
- 1
- Pages
- 75-79
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W252619442
- Cited by
- 311
- References
- 19
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 6 · 2023: 3 · 2022: 6 · 2021: 7 · 2020: 7 · 2019: 6 · 2018: 16 · 2017: 6 · 2016: 11 · 2015: 9 · 2014: 17 · 2013: 11 · 2012: 18
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Menstrual Health and Disorders
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Keywords
- endometriosis, pelvic pain, goserelin, GnRH agonist, low-dose oral contraceptives, dysmenorrhea, deep dyspareunia, symptom recurrence, treatment efficacy
- MeSH terms
- Adolescent, Adult, Contraceptives, Oral, Dysmenorrhea, Dyspareunia, Endometriosis, Female, Follow-Up Studies, Humans, Pain, Recurrence, Goserelin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review